Skip to main content

Table 2 Clinicopathological data of patients with EGC and univariate analysis of risk factors for lymph node metastasis

From: Risk factors for lymph node metastasis in early gastric cancer patients: Report from Eastern Europe country– Lithuania

  

LNM-

LNM+

p

Odds ratio (95% CI)

Gender

Male

99 (84.6%)

18 (15.4%)

p = 0.090

1.80 (0.92–3.55)

Female

76 (75.2%)

25 (24.8%)

Age

65.26 ± 12.17

66.91 ± 13.03

p = 0.433

Tumor localization

Lower 1/3

62 (78.5%)

17 (21.5%)

p = 0.457

Middle1/3

100 (80.0%)

25 (20.0%)

Upper 1/3

13 (92.9%)

1 (7.1%)

Tumor invasion

T1a

94 (94.9%)

5 (5.1%)

p = 0.001

8.82 (3.31–23.46)

T1b

81 (68.1%)

38 (31.9%)

Tumor differentiation

G1 & G2

100 (87.7%)

14 (12.3%)

p = 0.006

2.76 (1.36–8.57)

G3

75 (72.1%)

29 (22.4%)

Lymphovascular invasion

LV+

12 (40%)

18 (60%)

p = 0.001

9.78 (4.20–22.72)

LV-

163 (86.7%)

25 (13.3%)

Lauren classification

Diffuse & mix

59 (71.1%)

24 (28.9%)

p = 0.012

2.09 (1.20–3.64)

Intestinal

106 (86.2%)

17 (13.8%)

Tumor size

≤2 cm

91 (86.7%)

14 (13.3%)

p = 0.026

2.27 (1.12–4.59)

>2 cm

83 (74.1%)

29 (25.9%)

Ulceration

Ulcerated

58 (74.4%)

20 (25.6%)

p = 0.114

1.73 (0.88–3.42)

Non-ulcerated

116 (83.5%

23 (16.5%)

Signet ring cell

Yes

11 (73.3%)

4 (26.7%)

p = 0.513

1.46 (0.44–4.86)

No

149 (80.1%)

37 (19.9%)